We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DAITF market cap is 0. The company's latest EPS is JPY and P/E is N/A.
| Year End 31 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 41.13B | 44.99B | 48.71B | 43.46B | 45.1B |
| Operating Income | 4.55B | 5.36B | 5.7B | 6.55B | 5.21B |
| Net Income | 3.51B | 3.94B | 4.25B | 4.67B | 3.6B |
| Year End 31 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 46.75B | 54.25B | 57.74B | 64.94B | 70.55B |
| Total Liabilities | 15.4B | 17.38B | 15.82B | 17.27B | 19.58B |
| Total Equity | 31.35B | 36.87B | 41.92B | 47.67B | 50.97B |
| Year End 31 May 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 6.89B | 4.31B | 5.18B | 4.37B | 4.16B |
| Investing | -3.87B | -2.68B | -6.32B | -4.4B | -5.57B |
| Financing | -2.9B | -350.46M | 1.42B | 989M | 618M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 15.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 9.84 (39.36%) |
| Company Name | Daito Pharmaceutical Company Ltd (PK) |
| Address |
326 yokamachi toyama, toyama 939-8567 |
| Website | https://www.daitonet.co.jp |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
